Immediately after injection of its DNA into the host cell, T7 bacteriophage ensures favorable conditions for preservation of its genetic material. Viral DNA must be protected not only from the bacterial restriction enzyme but also from competition by other viral genomes which might enter and interfere with its multiplication. The gene 0.3 protein protects T7 DNA against the bacterial restriction enzyme (8) . Although most studies link superinfection exclusion with early phage genes (1, 3, 7) , the mechanism of exclusion remains a controversial subject (6) .
Pertinent to the work to be presented here are in vitro studies which showed that alkylation of 17 DNA interferes with transcription directed by Escherichia coli RNA polymerase (2) . During phage development, transcription by the host polymerase is the first event after DNA injection. Any interference with this process could lead to changes in expression of early genes which could, in turn, affect superinfection exclusion. The studies presented here were undertaken to demonstrate whether or not alkylation blocks superinfection exclusion. (A report of these results was presented at the 82nd Annual Meeting of the American Society for Microbiology, March, 1982, in Atlanta, Ga.)
For superinfection experiments, it is necessary to differentiate primary infecting phage from superinfecting phage. We thus chose the model of Benbasat et al. (1) . The primary infecting phage was the T7 amber mutant am28 (gene 5 coding for T7 DNA polymerase). This mutant is unable to develop in E. coli B (Su-) but synthesizes all phage proteins except T7 DNA polymerase. The superinfecting phage was wildtype T7, whose laboratory host is E. coli B. Our working hypothesis was as follows: should the primary infecting phage possess a functional superinfection exclusion system, a second phage could not develop within the cell. If, however, exclusion were to be blocked by alkylation of the primary infecting phage, the superinfecting (wild-type) phage could develop and produce plaques on E. coli B.
The bacterial strains, E. coli B (Su-) and E.
coli 011' (Su'), were described previously (4, 5).
Wild-type T7 and the T7 am28 (gene 5) mutant were from the collection of F. W. Studier. Alkylation of purified phage with methyl methane sulfonate has been described (4). Table 1 presents results of three superinfection experiments. When nonalkylated T7 am28 was added to bacterial cells in primary infection, it blocked the development of superinfecting T7 phage (lines 1 and 7). However, if the primary infecting phage was alkylated, the superinfecting phage expressed itself (line 2) and formed plaques on the nonpermissive host, but with somewhat less efficiency than T7 phage alone (line 3). Controls (lines 4 and 5) showed that neither alkylated nor nonalkylated T7 am28 formed plaques on the nonpermissive host. When both primary infecting and superinfecting phages were alkylated, phage titers remained low (line 6). Nonetheless, we cannot be certain that superinfecting phage was excluded, since the high inactivation of that virus (line 8) made it difficult to detect superinfection by the plaque test.
To further investigate the mechanism of exclusion, we looked at phage-specific protein synthesis in superinfected cells with two questions in mind: (i) does alkylation inhibit protein synthesis directed by the primary infecting phage, and (ii) after primary infection with alkylated phage, can we demonstrate the intracellular presence of a superinfecting phage?
The autoradiogram in Fig. 1A shows that protein synthesis was decreased or delayed, or Table 1 was used except that a semisynthetic medium (10) was substituted for broth. Phage-specific proteins were continuously labeled with [3 Smethionine (100 ,Ci/ml) in infected UVirradiated cells; the radioactive label was added at the time of primary infection. Samples were treated with cracking buffer (9) Benbasat et al. (1) showed that superinfection exclusion in T7 phage could be overcome if the bacterial culture were treated with chloramphenicol 5 min before primary infection. Our results show that alkylation of phage has an effect analogous to that of chloramphenicol. It thus appears that inhibition of phage-specific protein synthesis, whether by alkylation or by antibiotic action, leads to a breakdown of exclusion. Contradictory results (3, 7) may be explained by the shorter period of incubation of the bacterial culture with chloramphenicol.
In conclusion, we have shown that alkylation of 17 phage destroyed its defenses against competitive entry and development of homologous superinfecting virus. This blockage of superinfection exclusion for T7 phage is thus a newly discovered biological consequence of alkylation. Finally, the delay and inhibition of protein synthesis, documented here as being responsible for the breakdown of exclusion, may be an important factor in the inactivation of 17 phage by monofunctional alkylating agents.
